Nancy Hedges
Analyst · Craig-Hallum Capital Group
Thanks, Pete, and good afternoon, everyone. I'll walk through our first quarter results in more detail, provide some color by segment, review cash flow and the balance sheet and then close with key financial priorities for 2026. As Pete noted, Q1 was a solid start to the year with strong top line growth, meaningful margin expansion and record bookings and backlog that support our decision to raise the full year outlook. First quarter sales were $231 million, including $4.6 million from the BMA acquisition. Sales grew 12% from $206 million in the first quarter of 2025. Growth was driven primarily by strength in our Aerospace segment with continued robust demand in commercial transport, solid contributions from general aviation for VVIP projects and improving results in Test Systems. Gross profit increased to $75 million or 32.6% of sales compared with $61 million or 29.5% of sales in the prior year period. The 310 basis point gross margin expansion was driven by higher volume, improved productivity and a $2.8 million cumulative catch-up adjustment on the MV-75 program, which added about 120 basis points of margin based on updated program estimates. These benefits were partially offset by a $1.7 million increase in tariff expenses. Last year's first quarter also included a $1.9 million negative revision on a long-term mass transit contract in Test Systems, which depressed the prior year margin. R&D expense was about $12 million in the quarter, up modestly from $11 million a year ago, reflecting the timing of projects and consistent with our intent to continue investing in differentiated technology. Selling, general and administrative expense decreased slightly to $35.8 million from $36.6 million and declined as a percent of sales to 15.5% from 17.8% in the prior year, reflecting operating leverage and substantially lower litigation-related expense year-over-year, partially offset by higher wages, incentive compensation and incremental costs from the acquired BMA business. Income from operations more than doubled to $27.2 million from $13.1 million in the prior year quarter. On an adjusted basis, which excludes litigation-related items, ERP consulting and certain other nonrecurring items, operating income was $29.6 million, and adjusted operating margin was 12.8%, up 180 basis points from 11% in the prior year period. Interest expense was $2.3 million in the quarter, down $800,000 or 25.8% from $3.2 million a year ago, primarily reflecting the lower interest rate environment following our September 2025 refinancing. As you know, taxes have been quite variable in the last few years. In the quarter, we recorded a tax benefit of $800,000, driven largely by a $2.7 million discrete adjustment related to stock-based compensation, a valuation allowance reversal and the treatment of R&D costs. This compares with a $600,000 tax expense in the prior year period, which included a discrete $1.1 million benefit. While on the topic of taxes, I should point out that we expect in the coming quarters, possibly as early as the second quarter to meet the accounting requirements to release the valuation allowance related to our deferred tax assets, having demonstrated sufficient earnings power to utilize that asset. The reversal will result in a significant onetime tax benefit in the applicable quarter. Net income for the quarter was $25.5 million or $0.67 per diluted share compared with $9.5 million or $0.26 per diluted share in the first quarter of '25. Adjusted net income was $22.5 million, up 32.6% from $17 million last year. Adjusted diluted EPS in the 2026 first quarter was $0.59, up from $0.44 per diluted share in the prior year period. Adjusted EBITDA was $37.9 million in the quarter, up 23.3% from $30.7 million in the prior year period, and adjusted EBITDA margin expanded 150 basis points to 16.4% of sales. As Pete mentioned, this continues the margin improvement trajectory we've been focused on over the last several quarters. Weighted average diluted shares outstanding were 38.2 million in the quarter, down from 43 million in the prior year period. That decrease was largely driven by the repurchase of a portion of our outstanding convertible notes completed in 2025. Turning to the segments, starting with Aerospace. Aerospace segment sales were $213.8 million in the quarter, which is an increase of $22.4 million or 11.7%. Commercial transport sales increased 13.7% to $156.4 million, driven by higher demand for seat motion and lighting and safety products, along with continued strength in in-flight entertainment and connectivity or IFEC. General aviation sales grew 40.7% to $21.4 million, primarily on higher IFEC product sales into the VVIP market, while military aircraft sales were essentially flat year-over-year at $33.5 million. Other aerospace revenue declined by $2.9 million as we wound down noncore contract manufacturing arrangements. The other segment won't be as meaningful going forward, but does include some noncore machined products. Beginning this quarter, we've recast our product line sales to align with our strategic thrust, which we have been presenting supplementally in our investor presentations for several years. We believe this is a clearer and more effective presentation that explains the key drivers of the business. To provide perspective on the business by the new product categories, we've provided quarterly sales by product line for 2024 and 2025 as a supplemental table in the earnings release. Our largest product category is IFEC, which is comprised of passenger power as well as connectivity hardware, such as servers, modem managers, wireless access points, outside antenna equipment and associated kits. Revenue for these solutions was $110.7 million, up 7.4% year-over-year and representing just over 48% of our total sales. Our next largest product category is lighting and safety, which represents about 23% of sales and includes lighting for interior, exterior and cockpit lighting, including evacuation path lighting as well as safety equipment such as the passenger service units, emergency flashlights, survival kits and other emergency system solutions. Revenue for this product category increased 1.6% to $52.8 million. Flight critical electrical power is, as the name implies, critical to the operation of the aircraft. This includes starter generators, electronic circuit breakers and advanced switching technologies. Sales for this product category grew 16.2% to $24.8 million. Seat Motion revenue was historically reported within our former Electrical Power and Motion product group. The Seat Motion Product group has seen strong growth with sales of $13.2 million, up nearly 200% from $6.7 million in the prior year quarter, reflecting strong demand and the $4.6 million contribution of the BMA acquisition. Aerospace segment operating profit was $35.3 million or 16.5% of sales, an improvement from $22.3 million or 11.6% in the first quarter of '25. The improvement reflects higher volume, better production efficiencies, the MV-75 profit catch-up and a $7 million reduction in litigation-related expense and reserve adjustments related to the U.K. patent dispute, partially offset by higher tariffs. On an adjusted basis, Aerospace operating profit was $37.2 million and adjusted Aerospace operating margin expanded 120 basis points to 17.4%. Bookings in Aerospace were $264.4 million, up 11% sequentially and our second highest ever, trailing only the first quarter of 2025, which included the initial MV-75 engineering order. The Aerospace book-to-bill ratio was a very robust 1.24 with demand broad-based against product and market categories. Aerospace backlog reached a record $651.4 million at quarter end, up from $600.8 million at year-end 2025. That gives us strong visibility into the remainder of the year and underpins our raised outlook. Turning to Test Systems. Sales were $16.8 million in the quarter, up $2.2 million or 15.4% from $14.6 million in the prior year period. Again, recall that last year's first quarter sales and gross profit were negatively impacted by a $1.9 million cost estimate revision on a long-term mass transit contract, which reduced revenue and profit recognized in that period. Segment operating profit was slightly above breakeven at $400,000 compared with an operating loss last year. The benefits from our cost rationalization and simplification initiatives have continued to take hold and provide a solid foundation from which we can expand once the production order for the Army radio test program is received, which we expect in the next several weeks. Bookings for Test Systems were $26.1 million, resulting in a book-to-bill ratio of 1.55. Backlog for the segment ended the quarter at $83 million. We plan on announcing the rate the Army test program order when received and expect the order will contribute to revenue for a year or more. Turning to cash on the balance sheet. We generated $10.6 million of cash from operations in the first quarter compared to $20.6 million a year ago. The year-over-year difference reflects higher working capital requirements to support anticipated revenue growth including an increase in inventory, partially offset by higher cash earnings. Accounts receivable rose in line with sales, and we continue to manage past due balances and collections closely. Capital expenditures were $11.2 million in the quarter, up from $2.1 million a year ago as we continue to invest in capacity, productivity and facility consolidation. Elevated CapEx also reflects catch-up investments on previously deferred spending and the ongoing consolidation of operations and capacity expansion in our new Seattle facility, which we expect to complete here in the second quarter. As a reminder, we expect CapEx for full year 2026 to be in the range of $40 million to $45 million. We ended the quarter with total debt of $334.9 million, essentially unchanged from year-end, and cash and cash equivalents of $11.9 million. We had $231.8 million of available liquidity at year-end, which includes 19.1% of available cash -- I'm sorry, $19.1 million of available cash and undrawn capacity on our revolving credit facility. Our leverage position and liquidity provide us with flexibility to fund organic growth, support capital investments and advance our strategic initiatives. I'll also remind you that we're in the early phases of implementing a new global enterprise resource planning system. We expect to invest approximately $15 million to $17 million in 2026 on this initiative, excluding internal operating expenses, with $2 million to $3 million flowing through P&L as incremental operating expense and the remainder to be capitalized and reflected as a cash outflow from operations. Over the 5-year life of the project, we anticipate total spend of $35 million to $40 million, of which roughly $25 million will be capitalized. Before turning it back to Pete, I'll briefly summarize our outlook for the second quarter. We expect second quarter sales to be in the range of $245 million to $250 million, which would be a new quarterly record for our company. And we expect revenue to step up further in the second half of 2026 as the Army radio test program moves into production and our aerospace programs continue to ramp. From a margin standpoint, our focus remains on achieving sustainable high teens adjusted operating margins on a consolidated basis with continued progress toward that goal in '26. We expect to be supported by volume leverage, improved productivity, lower litigation costs and a richer mix within both Aerospace and Test. We also expect Test Systems profitability to improve meaningfully as volume builds on the U.S. Army radio test program and as we continue to execute on cost and mix initiatives. We're pleased with our start to 2026 and believe we're well positioned to deliver another year of strong growth and improved profitability. And with that, I'll turn it back to Pete for some final comments before we open the line for questions. Pete?